Gene-Environment Interactions and Susceptibility to Metabolic Syndrome and Other Chronic Diseases

被引:57
作者
Ordovas, Jose M. [1 ]
Shen, Jian [1 ]
机构
[1] Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Nutr & Genom Lab, Boston, MA 02111 USA
关键词
Diet; disease susceptibility; gene-environment interactions; genetics; inflammation; metabolic syndrome;
D O I
10.1902/jop.2008.080232
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
There is an intrinsic complexity in the pathogenesis of common diseases. The concept of gene-environment interaction is receiving support from emerging evidence coming primarily from studies involving diet and cardiovascular disease (CVD) and its various risk factors. The accumulating evidence shows that common variants at candidate genes for lipid metabolism, inflammation, and obesity are associated with altered plasma levels of classic and new biomarkers of metabolic syndrome and CVD risk. Major contributors to this knowledge have been a series of large population studies containing phenotype-rich databases and dietary information to which genetic data have been added. Although this approach has provided strong evidence supporting the concept of gene-diet interactions modulating CVD risk factors, the strength of the individual effect is very small, and the replication among studies is rather disappointing. Current population studies are starting to incorporate experimental and analytical approaches that could provide more solid and comprehensive results. However, other limitations, such as the size of the populations required to examine higher-level interactions, are still major obstacles to translating this knowledge into practical public health applications. Nevertheless, data from numerous molecular and genetic epidemiological studies provide tantalizing evidence suggesting that gene-environment interactions, i.e., the modulation by a genetic polymorphism of a dietary component effect on a specific phenotype (e.g., cholesterol levels and obesity), can interact in ways that increase the risk for developing chronic disease, including susceptibility to developing the metabolic syndrome. Once further experience is gained from patients and/or individuals at high risk, more personalized genetic-based approaches may be applied toward the primary prevention and treatment of CVDs and other complex inflammatory diseases. J Periodontol 2008;79:1508-1513.
引用
收藏
页码:1508 / 1513
页数:6
相关论文
共 35 条
[1]   Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? [J].
Barter, Philip J. ;
Rye, Kerry-Anne .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (01) :39-46
[2]   Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients [J].
Brisson, D ;
Ledoux, K ;
Bossé, Y ;
St-Pierre, J ;
Julien, P ;
Perron, P ;
Hudson, TJ ;
Vohl, MC ;
Gaudet, D .
PHARMACOGENETICS, 2002, 12 (04) :313-320
[3]   Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls [J].
Burton, Paul R. ;
Clayton, David G. ;
Cardon, Lon R. ;
Craddock, Nick ;
Deloukas, Panos ;
Duncanson, Audrey ;
Kwiatkowski, Dominic P. ;
McCarthy, Mark I. ;
Ouwehand, Willem H. ;
Samani, Nilesh J. ;
Todd, John A. ;
Donnelly, Peter ;
Barrett, Jeffrey C. ;
Davison, Dan ;
Easton, Doug ;
Evans, David ;
Leung, Hin-Tak ;
Marchini, Jonathan L. ;
Morris, Andrew P. ;
Spencer, Chris C. A. ;
Tobin, Martin D. ;
Attwood, Antony P. ;
Boorman, James P. ;
Cant, Barbara ;
Everson, Ursula ;
Hussey, Judith M. ;
Jolley, Jennifer D. ;
Knight, Alexandra S. ;
Koch, Kerstin ;
Meech, Elizabeth ;
Nutland, Sarah ;
Prowse, Christopher V. ;
Stevens, Helen E. ;
Taylor, Niall C. ;
Walters, Graham R. ;
Walker, Neil M. ;
Watkins, Nicholas A. ;
Winzer, Thilo ;
Jones, Richard W. ;
McArdle, Wendy L. ;
Ring, Susan M. ;
Strachan, David P. ;
Pembrey, Marcus ;
Breen, Gerome ;
St Clair, David ;
Caesar, Sian ;
Gordon-Smith, Katherine ;
Jones, Lisa ;
Fraser, Christine ;
Green, Elain K. .
NATURE, 2007, 447 (7145) :661-678
[4]  
Corella D, 2005, CURR OPIN MOL THER, V7, P569
[5]   Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high-saturated fat, low-carbohydrate diet [J].
Corella, Dolores ;
Qi, Lu ;
Tai, E. Shyong ;
Deurenberg-Yap, Mabel ;
Tan, Chee Eng ;
Chew, Suok Kai ;
Ordovas, Jose M. .
DIABETES CARE, 2006, 29 (06) :1313-1319
[6]   Nutritional genomics in practice: Where do we begin? [J].
Debusk, RM ;
Fogarty, CP ;
Ordovas, JM ;
Kornman, KS .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2005, 105 (04) :589-598
[7]   A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity [J].
Deeb, SS ;
Fajas, L ;
Nemoto, M ;
Pihlajamäki, J ;
Mykkänen, L ;
Kuusisto, J ;
Laakso, M ;
Fujimoto, W ;
Auwerx, J .
NATURE GENETICS, 1998, 20 (03) :284-287
[8]   The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease [J].
Haffner, SM .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (2A) :3A-11A
[9]   Risk factors for myocardial infarction and death in newly detected NIDDM: The diabetes intervention study, 11-year follow-up [J].
Hanefeld, M ;
Fischer, S ;
Julius, U ;
Schulze, J ;
Schwanebeck, U ;
Schmechel, H ;
Ziegelasch, HJ ;
Lindner, J .
DIABETOLOGIA, 1996, 39 (12) :1577-1583
[10]   Genetic variation at the perilipin locus is associated with changes in serum free fatty acids and abdominal fat following mild weight loss [J].
Jang, Y. ;
Kim, O. Y. ;
Lee, J. H. ;
Koh, S. J. ;
Chae, J. S. ;
Kim, J. Y. ;
Park, S. ;
Cho, H. ;
Lee, J. E. ;
Ordovas, J. M. .
INTERNATIONAL JOURNAL OF OBESITY, 2006, 30 (11) :1601-1608